Clinicopathological Features of Insulinoma: A Single Tertiary Center Experience

被引:0
作者
Mehmet Sözen
Zeynep Cantürk
Alev Selek
Berrin Çetinarslan
Baldan Huri Eryılmaz
Emre Gezer
Damla Köksalan
机构
[1] Kocaeli University Faculty of Medicine,Department of Endocrinology and Metabolism
[2] Kocaeli University Faculty of Medicine,Department of Internal Medicine
来源
Indian Journal of Surgical Oncology | 2023年 / 14卷
关键词
Insulinoma; Hypoglycemia; PanNET; Pancreas;
D O I
暂无
中图分类号
学科分类号
摘要
Insulinoma is a rare pancreatic neuroendocrine tumor with an incidence of 1–4 cases per million. Here we present our 10 years of experience in 13 cases of insulinoma. We retrospectively reviewed all insulinoma patients diagnosed and treated between 2012 and 2022. Clinical and pathological features, diagnostic methods, and follow-up results of insulinoma patients were discussed. A total of 13 patients were included in this study (7 men, and 6 women). The mean age at the time of diagnosis was 58 (36.5–70.5) years. There is only one patient diagnosed with MEN-1 syndrome. The mean time from the onset of symptoms to the diagnosis was 15 (7–27.5) months. In the prolonged fasting test, symptomatic hypoglycemia occurred in all patients within 48 h. The median size of lesions was 15 (12–24) mm, and 46.2% of these lesions were isolated in the pancreatic tail. Ga-68 DOTATATE PET/CT detected lesions with 100% accuracy. Three patients met the criteria for malignant insulinoma. Octreotide LAR was given to 1 patient with metastatic disease and 1 patient who did not accept surgery. The metastatic patient received 8 cycles of Lu treatment and died after 51 months of follow-up. The diagnosis of insulinoma can be challenging. The 48-h fasting test period provided sufficient information for the diagnosis of insulinoma. Ga-68 DOTATATE PET/CT may be an alternative in cases where cross-sectional imaging cannot localize the pancreatic lesion.
引用
收藏
页码:564 / 570
页数:6
相关论文
共 68 条
  • [1] Service FJ(1991)Functioning Insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study Mayo Clin Proc 66 711-719
  • [2] Mcmahon MM(2007)Endoscopic ultrasonography (EUS) in the localization of insulinoma Endocrine 31 238-241
  • [3] Obrien PC(2013)Malignant insulinoma: Recommendations for characterisation and treatment Insulinome malin : caractérisation et traitement ♦ Ann Endocrinol (Paris) 74 523-533
  • [4] Ballard DJ(2014)MANAGEMENT OF ENDOCRINE DISEASE: A clinical update on tumor-induced hypoglycemia Eur J Endocrinol 170 R147-R157
  • [5] Sotoudehmanesh R(2013)Diagnosis and management of insulinoma World J Gastroenterol 19 829-837
  • [6] Hedayat A(2022)Evaluation of insulinoma cases presented with hyperinsulinemic hypoglycemia: a single-centre experience Turkish J Intern Med 4 23-28
  • [7] Shirazian N(2020)Surgical management of insulinomas at the Azerbaijan Medical University: a retrospective study of 21 cases over a 10-year period Turkish J Med Sci 50 1262-1269
  • [8] Baudin E(2021)Insulinoma: spectrum of clinicopathological features in a tertiary center Istanbul Med J 22 61-67
  • [9] Caron P(2016)Evolving management of insulinoma: experience at a tertiary care centre Indian J Med Res 144 771-630
  • [10] Lombard-Bohas C(2014)Insulinoma case series: experience of a tertiary care center Indian J Endocrinol Metab 18 858-447